Evidence map›Paper›PMID 36292461›Full record

ReviewHealthcare (Basel, Switzerland)2022

Leveraging Telehealth for the Management of Breast Cancer: A Systematic Review.

Clemens Scott Kruse, Gerardo J Pacheco, Brea Vargas, Nadya Lozano, Sergio Castro, Manasa Gattu

Abstract readReview
In one paragraph

Review in Healthcare (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Clemens Scott KruseSchool of Health Administration, Texas State University, 601 University Drive, San Marcos, TX 78666, USA.ORCID 0000-0002-7636-1086
Gerardo J PachecoSchool of Health Administration, Texas State University, 601 University Drive, San Marcos, TX 78666, USA.
Brea VargasSchool of Health Administration, Texas State University, 601 University Drive, San Marcos, TX 78666, USA.
Nadya LozanoSchool of Health Administration, Texas State University, 601 University Drive, San Marcos, TX 78666, USA.ORCID 0000-0002-6428-0174
Sergio CastroSchool of Health Administration, Texas State University, 601 University Drive, San Marcos, TX 78666, USA.
Manasa GattuSchool of Health Administration, Texas State University, 601 University Drive, San Marcos, TX 78666, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBreast cancer affects 2.3 million women and kills 685,000 globally, making it the most prevalent cancer. The telemedicine modality has been used to treat the symptoms associated with breast cancer recovery.

objectivesTo analyze the effectiveness of telemedicine to help women recover from the treatment-associated effects and promote overall recovery from breast cancer.

methodsFour databases were queried for published literature from the last 10 years. The systematic literature review was conducted in accordance with the Kruse Protocol and reported in accordance with PRISMA 2020.

resultsFive interventions were identified in the literature, with the most dominant being eHealth and mHealth. The other interventions were telephone, video teleconference, and a combination of eHealth and mHealth. There were positive effects of these telemedicine interventions in 88% of the studies analyzed. Telemedicine is shown to positively affect physical and mental health, sleep outcomes, quality of life, and body image. The largest barriers to the adoption of telemedicine interventions are training, cost, workflow, time of providers, and low reimbursement.

conclusionTelemedicine offers promise to both providers and breast cancer survivors to improve the physical and mental health detriments of both cancer and its associated treatments. It also helps women develop healthy habits to reduce the risk of reoccurrence.

Indexed as

breast cancermHealthtelemedicine

Identifiers

PMID36292461
PMCPMC9602569

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.